Login

Ownership

Who owns Cardiol Therapeutics Inc, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).

Stakes over 5%

Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.

MMCAP International Inc. SPC, MM Asset Management Inc. August 14, 2026

MMCAP International Inc. SPC: 17.6% · 21,310,099 shares — MM Asset Management Inc.: 17.6% · 21,310,099 shares

Tejara Capital Ltd October 23, 2025

Tejara Capital Ltd: 5.2% · 5,130,122 shares

Super investors holding CRDL

Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of Cardiol Therapeutics Inc they hold. Together these 67 managers report 47.32% of shares outstanding.

Investor Position value Shares % of their portfolio % of company As of
MMCAP International Inc. SPC $16.5M 15,598,560 1.40% 23.87% June 30, 2026
Tejara Capital Ltd $5.42M 5,113,822 2.23% 7.83% June 30, 2026

65 more institutional holders behind a free account

See every manager reporting Cardiol Therapeutics Inc, how much of the company they hold, and how big the position is inside their own portfolio.

Sign up free

Funds holding CRDL

Funds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets. Together these 3 funds hold 1.00% of shares outstanding — counted inside the manager totals above, not on top of them, since a fund's shares also appear in its manager's 13F.

Fund Position value % of net assets % of company As of
AdvisorShares Pure Cannabis ETF $570K 1.37% 0.92% December 31, 2025
Fidelity Nasdaq Composite Index Fund $53.5K 0.00% 0.08% February 28, 2026

1 more funds behind a free account

See every fund holding Cardiol Therapeutics Inc and what share of its net assets the position represents.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support